137 related articles for article (PubMed ID: 1846070)
1. Inhibition of tumour-induced lipolysis in vitro and cachexia and tumour growth in vivo by eicosapentaenoic acid.
Tisdale MJ; Beck SA
Biochem Pharmacol; 1991 Jan; 41(1):103-7. PubMed ID: 1846070
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia.
Tisdale MJ
Nutrition; 1996 Jan; 12(1 Suppl):S31-3. PubMed ID: 8850217
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory protein.
Tisdale MJ
Prostaglandins Leukot Essent Fatty Acids; 1993 Jan; 48(1):105-9. PubMed ID: 8380931
[TBL] [Abstract][Full Text] [Related]
4. Effect of eicosapentaenoic acid (EPA) on expression of a lipid mobilizing factor in adipose tissue in cancer cachexia.
Russell ST; Tisdale MJ
Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):409-14. PubMed ID: 15899583
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of inhibition of a tumor lipid-mobilizing factor by eicosapentaenoic acid.
Price SA; Tisdale MJ
Cancer Res; 1998 Nov; 58(21):4827-31. PubMed ID: 9809986
[TBL] [Abstract][Full Text] [Related]
6. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover.
Beck SA; Smith KL; Tisdale MJ
Cancer Res; 1991 Nov; 51(22):6089-93. PubMed ID: 1657378
[TBL] [Abstract][Full Text] [Related]
7. Effect of n-3 fatty acids on the antitumour effects of cytotoxic drugs.
Wynter MP; Russell ST; Tisdale MJ
In Vivo; 2004; 18(5):543-7. PubMed ID: 15523890
[TBL] [Abstract][Full Text] [Related]
8. Docosahexaenoic acid-enriched phospholipids and eicosapentaenoic acid-enriched phospholipids inhibit tumor necrosis factor-alpha-induced lipolysis in 3T3-L1 adipocytes by activating sirtuin 1 pathways.
Yang YH; Hao YM; Liu XF; Gao X; Wang BZ; Takahashi K; Du L
Food Funct; 2021 Jun; 12(11):4783-4796. PubMed ID: 34100500
[TBL] [Abstract][Full Text] [Related]
9. EPA-enriched phospholipids ameliorate cancer-associated cachexia mainly via inhibiting lipolysis.
Du L; Yang YH; Wang YM; Xue CH; Kurihara H; Takahashi K
Food Funct; 2015 Dec; 6(12):3652-62. PubMed ID: 26373883
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of the inhibition of tumour growth in mice by eicosapentaenoic acid-reversal by linoleic acid.
Hudson EA; Beck SA; Tisdale MJ
Biochem Pharmacol; 1993 Jun; 45(11):2189-94. PubMed ID: 8517859
[TBL] [Abstract][Full Text] [Related]
11. Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF).
Islam-Ali B; Khan S; Price SA; Tisdale MJ
Br J Cancer; 2001 Sep; 85(5):758-63. PubMed ID: 11531264
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
[TBL] [Abstract][Full Text] [Related]
13. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.
Mahony SM; Beck SA; Tisdale MJ
Br J Cancer; 1988 Apr; 57(4):385-9. PubMed ID: 3390373
[TBL] [Abstract][Full Text] [Related]
14. Mechanism for the antitumor and anticachectic effects of n-3 fatty acids.
Sauer LA; Dauchy RT; Blask DE
Cancer Res; 2000 Sep; 60(18):5289-95. PubMed ID: 11016660
[TBL] [Abstract][Full Text] [Related]
15. Eicosapentaenoic acid inhibits tumour necrosis factor-α-induced lipolysis in murine cultured adipocytes.
Lorente-Cebrián S; Bustos M; Marti A; Fernández-Galilea M; Martinez JA; Moreno-Aliaga MJ
J Nutr Biochem; 2012 Mar; 23(3):218-27. PubMed ID: 21497077
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 polyunsaturated fatty acids ameliorate ethanol-induced adipose hyperlipolysis: A mechanism for hepatoprotective effect against alcoholic liver disease.
Wang M; Zhang X; Ma LJ; Feng RB; Yan C; Su H; He C; Kang JX; Liu B; Wan JB
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3190-3201. PubMed ID: 28847514
[TBL] [Abstract][Full Text] [Related]
17. Lipolytic factors associated with murine and human cancer cachexia.
Beck SA; Mulligan HD; Tisdale MJ
J Natl Cancer Inst; 1990 Dec; 82(24):1922-6. PubMed ID: 2250313
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effectiveness of eicosapentaenoic acid administered as either the free acid or ethyl ester as an anticachectic and antitumour agent.
Hudson EA; Tisdale MJ
Prostaglandins Leukot Essent Fatty Acids; 1994 Aug; 51(2):141-5. PubMed ID: 7972268
[TBL] [Abstract][Full Text] [Related]
19. Eicosapentaenoic acid (EPA) vs. Docosahexaenoic acid (DHA): Effects in epididymal white adipose tissue of mice fed a high-fructose diet.
Bargut TCL; Santos LP; Machado DGL; Aguila MB; Mandarim-de-Lacerda CA
Prostaglandins Leukot Essent Fatty Acids; 2017 Aug; 123():14-24. PubMed ID: 28838556
[TBL] [Abstract][Full Text] [Related]
20. Interaction of low dose of fish oil and glucocorticoids on insulin sensitivity and lipolysis in healthy humans: A randomized controlled study.
Delarue J; Allain-Jeannic G; Guillerm S; Cruciani-Guglielmacci C; Magnan C; Moineau MP; Le Guen V
Mol Nutr Food Res; 2016 Apr; 60(4):886-96. PubMed ID: 26821227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
